The 2 most recent market catalysts affecting $CRNX, each scored for sentiment and estimated stock impact. Sourced from SEC EDGAR filings and financial news, analysed automatically as they are published.
Nov 14, 2026
Corporate Catalyst
Bearish
Impact 92
Curanex Pharmaceuticals Reports Third Quarter 2026 Financial Results
Curanex Pharmaceuticals disclosed its Q3 2026 financial results, revealing zero revenue, a widened operating loss of $2.82 million (from $0.95 million year-over-year), and diluted …
Sep 2, 2026
Corporate Catalyst
Bearish
Impact 55
Cantor Fitzgerald Suspends Neutral Rating on Crinetics Pharmaceuticals
Cantor Fitzgerald has suspended its Neutral rating on Crinetics Pharmaceuticals. This action means that the firm is no longer actively recommending a 'Neutral' stance on the stock,…
Not financial advice. AI-generated analysis for informational purposes only. Tradow AI LLC is not a registered investment adviser.